Trojan Extended Pleasure

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the prevention of premature ejaculation in adult males. It assists in temporarily prolonging the time until ejaculation, thereby enhancing control during sexual activity.

Dosage and Administration

The product should be applied as a small amount to the head and shaft of the penis prior to intercourse, or as directed by a healthcare professional. It is essential to wash the product off after intercourse. The application should only be performed on intact, non-inflamed skin to ensure safety and efficacy.

Prior to engaging in intercourse, the product must be allowed to dry completely. It is recommended to use the product no more than four times per day. This product is not suitable for oral use and should be used strictly as directed.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. In the event of swallowing, immediate medical assistance or contact with a Poison Control Center is advised.

Warnings and Precautions

For external use only. This product is intended solely for topical application and should not be ingested.

Premature ejaculation may be indicative of an underlying condition that necessitates medical supervision. If the product, when used as directed, fails to provide relief, it is imperative to discontinue use and seek consultation with a healthcare professional.

Care should be taken to avoid contact with the eyes. In the event of accidental contact, it is advisable to rinse thoroughly with water and seek medical attention if irritation persists.

Should either the user or their partner experience a rash or irritation, such as burning or itching, the use of this product must be discontinued immediately. If symptoms persist despite discontinuation, consultation with a healthcare provider is recommended.

In the case of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center without delay.

Side Effects

Patients using this product should be aware that it is intended for external use only. It is important to note that premature ejaculation may be indicative of an underlying condition that requires medical supervision. If the product does not provide relief when used as directed, patients are advised to discontinue use and consult a healthcare professional.

Additionally, care should be taken to avoid contact with the eyes. In the event that either the patient or their partner experiences a rash or irritation, such as burning or itching, it is recommended to discontinue use immediately. Should these symptoms persist, consulting a doctor is advised.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Trojan Extended Pleasure (benzocaine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of Trojan Extended Pleasure Delay Spray in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing this product to geriatric patients, as the absence of specific data necessitates careful clinical judgment. Monitoring for any adverse effects or unusual responses in this population is advisable.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and breastfeeding safety. Healthcare providers can offer guidance tailored to individual circumstances, ensuring the health and safety of both the patient and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, unusual behavioral changes, or any other atypical clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while specific overdosage information is not available, healthcare professionals should exercise caution, monitor for symptoms, and provide appropriate supportive care in the event of an overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's safety profile in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is important to emphasize that if the medication is swallowed, patients should seek medical help or contact a Poison Control Center immediately. This guidance is crucial for ensuring patient safety and minimizing potential risks associated with accidental exposure.

Storage and Handling

The product is supplied in packaging that includes an NDC number for identification. It should be stored at a temperature range of 20-30°C (68-86ºF) to maintain its integrity and efficacy. Healthcare professionals are advised to inspect the carton for a safety seal; the product should not be used if the safety seal is broken or missing, as this may compromise the product's safety and effectiveness.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Trojan Extended Pleasure, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)